Research Article
Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices
Table 1
Validation of the Baveno VI criteria.
| Author | Research population (, etiology) | Prevalence of HRV (, %) | Spared endoscopy | Missed HRVs/saved endoscopies | Missed HRVs/total HRVs |
| Maurice [48] | 310, mixed | 15 (5%) | 102/310 (33.0%) | 2/102 (2.0%) | 2/15 (13.3%) | Jangouk [66] | 262, mixed US cohort (161) | 14 (9%) | 41/161 (25.4%) | 0/41 (0%) | 0/14 (0%) | Italian cohort (101) | 17 (17%) | 16/101 (15.8%) | 0/16 (0%) | 0/17 (0%) | Sousa [72] | 104, mixed | 9 (9%) | 48/104 (46.2%) | 0/48 (0%) | 0/9 (0%) | Wong [58] | 127, mixed | 11 (9%) | 105/127 (82.7%) | 1/105 (1.0%) | 1/11 (9.1%) | Petta [32] | 790, NAFLD | | | | | Training cohort (314) | 32 (10%) | 106/314 (33.8%) | 1/106 (0.9%) | 1/32 (3.1%) | Validation cohort (338) | 45 (13%) | 113/338 (33.4%) | 5/113 (4.4%) | 5/45 (11.1%) | Bae [51] | 282, mixed | 55 (20%) | 78/282 (27.6%) | 3/78 (3.8%) | 3/55 (5.5%) | Colecchia [63] | 498, mixed | | | | | Internal cohort (240) | 46 (19%) | 52/240 (21.7%) | 1/52 (1.9%) | 1/46 (2.2%) | External cohort (115) | 15 (13%) | 19/115 (16.5%) | 0/19 (0%) | 0/15 (0%) | Tosetti [68] | 442, mixed | 31 (7%) | 86/442 (19.5%) | 0/86 (0%) | 0/31 (0%) | Lee [53] | 1218, mixed | 249 (20%) | 313/1218 (25.7%) | 6/313 (1.9%) | 6/249 (2.4%) | Stefanescu [64] | 185, mixed | 43 (23%) | 15/185 (8.1%) | 0/15 (0%) | 0/43 (0%) | Gaete [73] | 300, mixed | 54 (18%) | 95/300 (31.7%) | 1/95 (1.1%) | 1/54 (1.9%) | Moctezuma-Velazquez [33] | 227, PBC, PSC | 30 (13%) | 82/227 (36.1%) | 0/82 (0%) | 0/30 (0%) | Protopapas [71] | 107, mixed | 22 (21%) | 13/107 (12.1%) | 0/13 (0%) | 0/22 (0%) |
|
|
Note: HRV—high-risk varices; NAFLD—nonalcoholic fatty liver disease; PBC—primary biliary cholangitis; PSC—primary sclerosing cholangitis.
|